Literature DB >> 13677570

Oral pharmacotherapy of childhood movement disorders.

Terence S Edgar1.   

Abstract

Movement disorders, a common problem in children with neurologic impairment, are receiving increasing clinical attention. The differences in movement disorders between adults and children are striking; presentation is frequently insidious and may be characterized by mild hypotonia. The clinical manifestations of extrapyramidal disorders are profoundly influenced by the age of onset. The conditions reviewed in this article are expressed clinically by the occurrence of abnormalities of movement and posture, often in association with disturbances of muscle tone. This article reviews empiric drug use and recommendations for childhood movement disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13677570     DOI: 10.1177/0883073803018001S0601

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

Review 1.  Principles of Medical and Surgical Treatment of Cerebral Palsy.

Authors:  Eric M Chin; Hilary E Gwynn; Shenandoah Robinson; Alexander H Hoon
Journal:  Neurol Clin       Date:  2020-05       Impact factor: 3.806

Review 2.  Pharmacologic interventions for reducing spasticity in cerebral palsy.

Authors:  Dilip R Patel; Olufemi Soyode
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

3.  An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

Authors:  Kathleen G Walker; Jo M Wilmshurst
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

4.  Prospective Randomized Study of Oral Diazepam and Baclofen on Spasticity in Cerebral Palsy.

Authors:  Vinay Goyal; Nonica Laisram; Ranjan Kumar Wadhwa; Shashank Yashwant Kothari
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 5.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.